journal article·2024-03Open access

Oral Carbon Monoxide Enhances Autophagy Modulation in Prostate, Pancreatic, and Lung Cancers

Jianling Bi, Emily Witt, Megan K. McGovern, Arielle B. Cafi, Lauren L. Rosenstock, Anna B. Pearson, Timothy J. Brown, Thomas B. Karasic, Lucas C. Absler, Srija Machkanti, Hannah Boyce, David Gallo, Sarah L. Becker, Keiko Ishida, Joshua Jenkins, Alison Hayward, Alexandra Scheiflinger, Kellie L. Bodeker, Ritesh Kumar, Scott K. Shaw, Salma K. Jabbour, Vitor A. Lira, Michael D. Henry, Michael S. Tift, Leo E. Otterbein, Giovanni Traverso, James D. Byrne

Advanced Science· Volume 11· Issue 9

Abstract

Abstract Modulation of autophagy, specifically its inhibition, stands to transform the capacity to effectively treat a broad range of cancers. However, the clinical efficacy of autophagy inhibitors has been inconsistent. To delineate clinical and epidemiological features associated with autophagy inhibition and a positive oncological clinical response, a retrospective analysis of patients is conducted treated with hydroxychloroquine, a known autophagy inhibitor. A direct correlation between smoking status and inhibition of autophagy with hydroxychloroquine is identified. Recognizing that smoking is associated with elevated circulating levels of carbon monoxide (CO), it is hypothesized that supplemental CO can amplify autophagy inhibition. A novel, gas‐entrapping material containing CO in a pre‐clinical model is applied and demonstrated that CO can dramatically increase the cytotoxicity of autophagy inhibitors and significantly inhibit the growth of tumors when used in combination. These data support the notion that safe, therapeutic levels of CO can markedly enhance the efficacy of autophagy inhibitors, opening a promising new frontier in the quest to improve cancer therapies.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Autophagy in Disease and Therapy · Heme Oxygenase-1 and Carbon Monoxide · Neonatal Health and Biochemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiation Oncology University of Iowa 200 Hawkins Drive Iowa City IA 52242 USA

Department of Biomedical Engineering University of Iowa 200 Hawkins Drive Iowa City IA 52242 USA

Holden Comprehensive Cancer Center University of Iowa Iowa City IA 52242 USA

Department of Biology and Marine Biology University of North Carolina Wilmington Wilmington NC 28403 USA

Abramson Cancer Center University of Pennsylvania Philadelphia PA 19146 USA

Simmons Comprehensive Cancer Center University of Texas Southwestern Medical Center Dallas TX 75390 USA

Carver College of Medicine University of Iowa Iowa City IA 52242 USA

Department of Chemical Engineering Massachusetts Institute of Technology 25 Ames St. Cambridge MA 02139 USA

David H. Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology 500 Main St Building 76 Cambridge MA 02142 USA

Department of Surgery Beth Israel Deaconess Medical Center Harvard Medical School 3 Blackfan Circle Boston MA 02215 USA

Division of Gastroenterology Brigham and Women's Hospital Harvard Medical School 75 Francis St. Boston MA 02115 USA

School of Medicine Oregon Health and Science University Portland OR 97239 USA

Department of Mechanical Engineering Massachusetts Institute of Technology 77 Massachusetts Ave Cambridge MA 02139 USA

Division of Comparative Medicine Massachusetts Institute of Technology Cambridge MA 02139 USA

Department of Radiation Oncology Rutgers Cancer Institute of New Jersey Robert Wood Johnson Medical School New Brunswick NJ 08903 USA

Department of Chemistry The University of Iowa Iowa City IA 52242 USA

Department of Health & Human Physiology University of Iowa Iowa City IA 52242 USA

Department of Molecular Physiology and Biophysics Carver College of Medicine University of Iowa Iowa City IA 52242 USA

Funding

U.S. Department of Defense · National Football League Players Association · National Science Foundation · National Cancer Institute · Prostate Cancer Foundation

References (40)

Show source-provided references
1. 10.1038/s43587-021-00098-410.1038/s43587-021-00098-4 ↗
2. 10.1038/s41556-018-0092-510.1038/s41556-018-0092-5 ↗
3. 10.1038/nrc.2017.5310.1038/nrc.2017.53 ↗
4. 10.1080/15548627.2022.203889910.1080/15548627.2022.2038899 ↗
5. 10.1038/s41416-022-01892-610.1038/s41416-022-01892-6 ↗
6. 10.1245/s10434-015-4566-410.1245/s10434-015-4566-4 ↗
7. 10.1007/s10637-014-0159-510.1007/s10637-014-0159-5 ↗
8. 10.18632/oncotarget.506010.18632/oncotarget.5060 ↗
9. 10.1200/JCO.2017.35.6_suppl.10210.1200/JCO.2017.35.6_suppl.102 ↗
10. 10.1158/1078-0432.CCR-18-220410.1158/1078-0432.CCR-18-2204 ↗
11. 10.1634/theoncologist.2018-062110.1634/theoncologist.2018-0621 ↗
12. 10.1093/oncolo/oyac07810.1093/oncolo/oyac078 ↗
13. 10.1001/jamaoncol.2019.068410.1001/jamaoncol.2019.0684 ↗
14. 10.4161/auto.2923110.4161/auto.29231 ↗
15. 10.1016/j.ctarc.2019.10015810.1016/j.ctarc.2019.100158 ↗
16. 10.4161/auto.2911910.4161/auto.29119 ↗
17. 10.4161/auto.2898410.4161/auto.28984 ↗
18. 10.1634/theoncologist.2014-008610.1634/theoncologist.2014-0086 ↗
19. 10.1158/1078-0432.CCR-19-404210.1158/1078-0432.CCR-19-4042 ↗
20. 10.3389/fphar.2020.0040810.3389/fphar.2020.00408 ↗
21. 10.3390/antiox1102032710.3390/antiox11020327 ↗
22. 10.1016/j.molcel.2011.04.02910.1016/j.molcel.2011.04.029 ↗
23. 10.1165/rcmb.2010-0352OC10.1165/rcmb.2010-0352OC ↗
24. 10.1158/0008-5472.CAN-21-315510.1158/0008-5472.CAN-21-3155 ↗
25. 10.1038/s41419-018-1112-x10.1038/s41419-018-1112-x ↗
26. 10.1126/scitranslmed.abl413510.1126/scitranslmed.abl4135 ↗
27. 10.1002/advs.20220599510.1002/advs.202205995 ↗
28. 10.1371/journal.pone.020519410.1371/journal.pone.0205194 ↗
29. 10.1038/ncomms895110.1038/ncomms8951 ↗
30. 10.1089/ars.2010.348810.1089/ars.2010.3488 ↗
31. 10.3389/fcell.2020.0003110.3389/fcell.2020.00031 ↗
32. 10.1016/j.archoralbio.2019.10464610.1016/j.archoralbio.2019.104646 ↗
33. 10.1016/j.biomaterials.2020.12019310.1016/j.biomaterials.2020.120193 ↗
34. 10.1158/0008-5472.CAN-13-107510.1158/0008-5472.CAN-13-1075 ↗
35. 10.1172/jci.insight.12403910.1172/jci.insight.124039 ↗
36. 10.1016/j.chest.2017.09.05210.1016/j.chest.2017.09.052 ↗
37. 10.1183/09031936.0016320610.1183/09031936.00163206 ↗
38. 10.1038/s41598-019-47308-z10.1038/s41598-019-47308-z ↗
39. 10.1093/clinchem/30.8.138210.1093/clinchem/30.8.1382 ↗
40. 10.1016/j.ab.2005.03.01910.1016/j.ab.2005.03.019 ↗